Advance the Development of Potent, Cross-Reactive Multispecific Antibodies for the Prep Countermeasure of Covid-19 and Seasonal and Highly Pathogenic Avian Influenza
Contract Overview
Contract Amount: $103,516,903 ($103.5M)
Contractor: Modex Therapeutics, Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2023-09-27
End Date: 2028-02-29
Contract Duration: 1,616 days
Daily Burn Rate: $64.1K/day
Official Description: ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
Place of Performance
Location: Massachusetts, 01760